WHWK Earnings Date: Nov 5, 2026 (Estimated) — Whitehawk Therapeutics Inc
NASDAQ · Healthcare · Biotechnology
Updated
When is WHWK's next earnings date?
Whitehawk Therapeutics Inc (WHWK) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 9:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.24.
How did WHWK do in its last earnings report?
In its most recent report on Aug 6, 2026 (Q2 2026), Whitehawk Therapeutics Inc posted EPS of -$0.20 versus the -$0.30 estimate, a beat of 28.6%. Revenue was $0 against a $-350,000 estimate. The stock's 1-day post-earnings move was +15.5%.
How much does WHWK stock move after earnings?
WHWK beat EPS estimates in 4 of its last 4 reported quarters. Over the last 5 reports the stock moved an average of 6.1% (up or down) in the day after earnings.
About Whitehawk Therapeutics Inc
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Q2 2026 | -0.30 | -0.20 | +28.57% | $0 | ✅ Beat | +15.48% | +15.72% | +13.76% |
| 2026-05-19 | Q1 2026 | -0.33 | -0.32 | +3.03% | $0 | ✅ Beat | -4.24% | +12.24% | -0.71% |
| 2026-03-12 | Q4 2025 | -0.38 | -0.34 | +10.53% | $0 | ✅ Beat | -2.74% | -4.99% | -15.46% |
| 2025-11-06 | Q3 2025 | -0.34 | -0.26 | +23.53% | $0 | ✅ Beat | -6.67% | -0.89% | +10.67% |
| 2025-03-18 | Q4 2024 | — | -0.67 | — | $7.2M | — | -1.46% | -4.88% | -24.88% |
Showing last 5 quarters.